Navigation Links
Gentium's Defibrotide Seen as Active in Multiple Myeloma

statements by forward-looking words such as "may," "might," "will," "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential" or "continue," the negative of these terms and other comparable terminology. These statements are not historical facts but instead represent the Company's belief regarding future results, many of which, by their nature, are inherently uncertain and outside the Company's control. It is possible that actual results may differ, possibly materially, from those anticipated in these forward-looking statements. For a discussion of some of the risks and important factors that could affect future results, see the discussion in our Form 20F filed with the Securities and Exchange Commission under the caption "Risk Factors."

Contact

Gentium
Gary Gemignani, 212-332-1666
Chief Financial Officer
ggemignani@gentium.com


'"/>




Page: 1 2 3

Related medicine technology :

1. Gentiums Defibrotide Highlighted in Poster Presentation at World Congress of Nephrology
2. Gentiums Defibrotide Highlighted in Two Poster Presentations at American Association for Cancer Research Annual Meeting
3. Controlling the Spread of Healthcare Associated Methicillin Resistant Staphylococcus aureus Requires Active Surveillance
4. In Vitro and In Vivo Data Show Alfacells Onocanse is Active Against Naive and Chemoresistant Neuroblastoma Cells
5. Active Biotech presents new pre-clinical data for the 57-57 project at the 8th World Congress on Inflammation
6. New Positive Pre-clinical Data for Active Biotechs RA Project I-3D
7. Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B Showed Significant Reductions in Disease Activity in Patients with Active Systemic Lupus Erythematosus
8. Fractionated Radioimmunotherapy With (90)Y-epratuzumab in Non-Hodgkins Lymphoma Appears Safe and Active in a Phase I/II Study
9. Treatment with Copaxone Plus Minocycline Showed Substantial Reduction of Disease Activity in Patients with Active Relapsing-Remitting Multiple Sclerosis
10. Treatment with Copaxone Plus Minocycline Showed Substantial Reduction of Disease Activity in Patients with Active Relapsing-Remitting Multiple Sclerosis
11. Copaxone Treatment over Two Years after Short Term Induction with Mitoxantrone Provided Sustained Benefits to Active Relapsing-Remitting Multiple Sclerosis Patients
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Gentium Defibrotide Seen Active Multiple Myeloma
(Date:3/31/2015)... -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD ) ("Galmed"), ... and commercialization of a once-daily, oral therapy for ... today announced financial results for the 12 months ... 2014 Highlights: , Hosted a key opinion ... Rohit Loomba, MD, MHSc., who discussed the topic ...
(Date:3/31/2015)... March 31, 2015   Unique Pharmaceuticals , a ... complete and the company has initiated sterile compounding operations ... goal as a company is to meet and exceed ... . "Meeting the new regulations is validation of our ... the future of our industry, investing in its continued ...
(Date:3/31/2015)... , March 31, 2015 ... today announced a strategic partnership with Medidata ... for clinical research in life sciences. Offering therapeutic ... CRO has deployed Medidata,s electronic data capture (EDC), ... Biorasi,s Phase I through IV global clinical trial ...
Breaking Medicine Technology:Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 2Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 3Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 4Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 5Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 6Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 7Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 8Unique Pharmaceuticals Launches Sterile Operations under New Federal Guidance 2Unique Pharmaceuticals Launches Sterile Operations under New Federal Guidance 3Biorasi Selects Medidata's Cloud-Based Platform for Optimal Trial Operations 2Biorasi Selects Medidata's Cloud-Based Platform for Optimal Trial Operations 3Biorasi Selects Medidata's Cloud-Based Platform for Optimal Trial Operations 4
... Oct. 3, 2011 Varian Medical Systems (NYSE: ... senior managers to support the company,s ongoing growth and ... Vice President for the company, has been named Chief ... development, production, promotion, and sale of all Varian products ...
...   PLC Medical Systems, Inc. (OTC: PLCSF) today announced ... , October 6, 2011TIME: , 11:00 AM ... "register/ watch event now" button.This will be a live, ... the company questions in real-time both in the presentation ...
Cached Medicine Technology:Varian Medical Systems Announces New Management Positions 2Varian Medical Systems Announces New Management Positions 3Varian Medical Systems Announces New Management Positions 4PLC Medical Systems to Present Webcast Live, at RetailInvestorConferences.com on October 6th 2
(Date:3/31/2015)... (PRWEB) March 31, 2015 Dr. Poneh Ghasri, ... offer patients valuable savings through new Spring specials. Dr. Poneh ... the holiday celebration this year by taking advantage of discounted ... , "Spring brings together friends and loved ones that want ... We are pleased to offer solutions for a great looking ...
(Date:3/31/2015)... Diane Blackburn-Zambetti is the Director of ... Research Foundation (Meso Foundation). Blackburn-Zambetti will present an ... the BoRit Asbestos Superfund Citizen Advisory Group Meeting ... discuss anatomy, six types of asbestos, asbestos products, ... prevention and proper communication with your healthcare provider. ...
(Date:3/31/2015)... A team of Italian scientists is using ... into mesothelioma cancer cells. Surviving Mesothelioma has just posted ... Click here to read it now. , ... the spice turmeric, has limited value as a cancer ... Università di Napoli Federico II are getting around the ...
(Date:3/31/2015)... MO (PRWEB) March 31, 2015 The ... 2015 from 5:00 to 8:00 pm at the SpringHill Suites ... hospitals, clinics and groups with career opportunities will be attending ... will enjoy free hors d’oeuvres and raffle prize drawings. , ... says “Denver is an ideal location to hold a career ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 The KIND LED K5 ... yields in the tightest of spaces. These large yields are due ... the packaged arrays. The KIND LED K5 grow lights use a ... efficiently amongst the 2 CM aluminum circuit boards that are the ... the KIND LED K35 lights are immense. The KIND LED K5 ...
Breaking Medicine News(10 mins):Health News:West Hollywood Cosmetic Dentist, Dr. Poneh Ghasri, is Now Offering Various Special Offers Just in Time for Spring 2Health News:Mesothelioma Foundation to speak at BoRit Asbestos Superfund Citizen Advisory Group Meeting 2Health News:New Research Reveals Novel Delivery Method for Potential Mesothelioma Treatment, According to Surviving Mesothelioma 2Health News:PracticeMatch to Host Physician Career Fair at SpringHill Suites Denver on April 8, 2015 2Health News:PracticeMatch to Host Physician Career Fair at SpringHill Suites Denver on April 8, 2015 3Health News:LED SuperNova Grow Box by SuperCloset Now Available with the KIND LED K5 Series 2
... their health are more successful at beating one of ... The study, funded by the federal Agency for Healthcare ... hypertension an electronic personal health record that enables them ... eat in their medical record and e-mail their physicians ...
... Very young brains process memories of fear differently than more ... Feb. 6 issue of The Journal of Neuroscience . ... fear is stored and unlearned, and introduces new thinking on ... important paper raises questions that are the tip of the ...
... and within countries, researcher notes , , WEDNESDAY, Feb. ... and within European countries in the rates of stroke ... example, rates of such deaths in several countries -- ... much as seven to 14 times higher than in ...
... Baycap Inc. ("Baycap"),today announced that it has donated ... Coordt and Peter Metropoulos, directors at Baycap,are Mira Costa ... the school with top of the line equipment and ... equipment will allow Mira Costa to add a third ...
... Society for Neuroscience (SfN), the worlds largest organization ... and nervous system, today released a new document ... but not limited to, those who face,intimidation, harassment, ... The,document, Best Practices for Protecting Researchers and ...
... Feb. 6 MarketResearch.com, a leading online,provider ... of key,findings on the global market for ... research publisher MarketStrat, Inc., Making available ... Specialty Medical Beds Therapeutic Surfaces Worldwide,MarketResearch.com provides ...
Cached Medicine News:Health News:Impact of electronic personal health record on hypertension under study 2Health News:Impact of electronic personal health record on hypertension under study 3Health News:Impact of electronic personal health record on hypertension under study 4Health News:Very young found to process fear memories in unique way 2Health News:Death Rates From Cardiovascular Causes Vary Widely Across Europe 2Health News:SfN releases 'Best Practices for Protecting Researchers and Research' 2Health News:MarketResearch.com Distributes Key Findings on Global Specialty Medical Beds and Therapeutic Surfaces Market 2
PremierEdge™ Stab Knives - 45°....
PremierEdge™ Stab Knives - 30°....
PremierEdge™ Stab Knives - 22.5°....
Lacrimal Intubation Set w/Retrieval Device. Size: Probes 23g x 4-1/4"....
Medicine Products: